Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 501 5th St, Bristol, Tennessee (TN) 37620-2304, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 1000208638 · DUNS 081301372
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-09-20
- VAIDrug Quality Assurance2019-04-12
- NAIDrug Quality Assurance2016-10-28
- VAIDrug Quality Assurance2015-08-14
- VAIDrug Quality Assurance2014-06-11
- VAIDrug Quality Assurance2012-11-13
- NAIDrug Quality Assurance2012-10-26
- NAIDrug Quality Assurance2011-04-08
- NAIDrug Quality Assurance2010-08-30
- NAIDrug Quality Assurance2010-08-09
- NAIDrug Quality Assurance2008-10-27
- OAIDrug Quality Assurance2008-10-27
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- belumosudilKadmon Pharmaceuticals, LLC
- PlecanatideSalix Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.